Lantern Pharma Inc. – Filings and Transcripts

NASDAQ: LTRN
Share price (8/17/26): $2.60
Market cap (8/17/26): $33.2 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025 – amended

ended 12/31/25 FY 2025

ended 09/30/25 Q3

Prospectuses and Registrations Filter

Initial registration of new securities

Exempt offering of securities

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Ownership Filter

Empery Asset Management, LP

Satterfield Thomas a Jr

Bios Equity Partners, LP

Schalop Lee Troy

Keyser D Jeffrey

News Filter

Reports Second Quarter 2026 Financial Results and Provides Business Update

Establishes Open-Medicine AI as a Separate Company to Commercialize and Expand Its Multi-Agent AI Co-Scientist Platform for the Transformation of Medicine

Material Disclosure, Financial Statements or Exhibits

Reports First Quarter 2026 Financial Results and Provides Business Updates

Announces Up to $9.25 Million Registered Direct Offering With Existing Holders and a Single Institutional Investor

Proxies Filter

Definitive proxy

Preliminary proxy

Definitive proxy

Definitive proxy

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC